NIAGEN BIOSCIENCE, INC. Finance Lease, Right-of-Use Asset, Amortization
NIAGEN BIOSCIENCE, INC. (NAGE) reported Finance Lease, Right-of-Use Asset, Amortization of $385.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2021-11-03
- NIAGEN BIOSCIENCE, INC. finance lease, right-of-use asset, amortization for the quarter ending 2021-09-30 was $131.00K, a 35.05% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. finance lease, right-of-use asset, amortization for the quarter ending 2021-06-30 was $128.00K, a 34.74% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. finance lease, right-of-use asset, amortization for the quarter ending 2021-03-31 was $126.00K, a 36.96% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. finance lease, right-of-use asset, amortization for the quarter ending 2020-12-31 was $115.00K, a 25.00% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. finance lease, right-of-use asset, amortization for fiscal 2020 was $399.00K, a 22.52% decline from fiscal 2019.
- NIAGEN BIOSCIENCE, INC. finance lease, right-of-use asset, amortization for fiscal 2019 was $515.00K.
- NIAGEN BIOSCIENCE, INC. finance lease, right-of-use asset, amortization for fiscal 2018 was $0.00.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 3 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|---|
| 2021-09-30 | $131.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $259.00K derived: sum of 2 quarters · filed 2021-11-03 | $385.00K 10-Q · filed 2021-11-03 | $500.00K derived: sum of 4 quarters · filed 2021-11-03 | |
| 2021-06-30 | $128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $254.00K 10-Q · filed 2021-08-03 | $369.00K derived: sum of 3 quarters · filed 2021-08-03 | $466.00K derived: sum of 4 quarters · filed 2021-11-03 | |
| 2021-03-31 | $126.00K 10-Q · filed 2021-05-06 | $241.00K derived: sum of 2 quarters · filed 2021-05-06 | $338.00K derived: sum of 3 quarters · filed 2021-11-03 | $433.00K derived: sum of 4 quarters · filed 2021-11-03 | |
| 2020-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $212.00K derived: sum of 2 quarters · filed 2021-11-03 | $307.00K derived: sum of 3 quarters · filed 2021-11-03 | $399.00K 10-K · filed 2021-03-12 | |
| 2020-09-30 | $97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $192.00K derived: sum of 2 quarters · filed 2021-11-03 | $284.00K 10-Q · filed 2021-11-03 | $376.00K derived: sum of 4 quarters · filed 2021-11-03 | |
| 2020-06-30 | $95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $187.00K 10-Q · filed 2021-08-03 | $279.00K derived: sum of 3 quarters · filed 2021-08-03 | $423.00K derived: sum of 4 quarters · filed 2021-08-03 | |
| 2020-03-31 | $92.00K 10-Q · filed 2021-05-06 | $184.00K derived: sum of 2 quarters · filed 2021-05-06 | $328.00K derived: sum of 3 quarters · filed 2021-05-06 | $469.00K derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $236.00K derived: sum of 2 quarters · filed 2021-03-12 | $377.00K derived: sum of 3 quarters · filed 2021-03-12 | $515.00K 10-K · filed 2021-03-12 | |
| 2019-09-30 | $144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $285.00K derived: sum of 2 quarters · filed 2020-11-04 | $423.00K 10-Q · filed 2020-11-04 | $423.00K derived: sum of 4 quarters · filed 2020-11-04 | |
| 2019-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $279.00K 10-Q · filed 2020-08-06 | $279.00K derived: sum of 3 quarters · filed 2020-08-06 | $279.00K derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $138.00K 10-Q · filed 2020-05-18 | $28.00K 10-Q · filed 2019-05-09 | $138.00K derived: sum of 2 quarters · filed 2020-05-18 | $138.00K derived: sum of 3 quarters · filed 2020-05-18 | $104.00K derived: sum of 4 quarters · filed 2020-05-18 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $0.00 derived: sum of 2 quarters · filed 2020-03-10 | -$34.00K derived: sum of 3 quarters · filed 2020-03-10 | $0.00 10-K · filed 2020-03-10 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$34.00K derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | -$34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $0.00 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | $34.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |